{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2016"],"condition":["Metastatic Colorectal Cancer"],"disease":["Metastatic Colorectal Cancer"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2665403"],"location":["China"],"study_start_month":["7"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Study on the New Technology of Traditional Chinese Medicine Combined with Molecular Targeted Therapy for the Treatment of Metastatic Colorectal Cancer","description":"Interventions: The treatment group:Chemotherapy + targeted therapy + HC particles;The control group:Chemotherapy + targeted therapy + placebo particles\nPrimary outcome(s): Progression-Free-Survival\nStudy Design: Randomized parallel controlled trial","dates":{"creation":"2016-07-15"},"accession":"2665403","cross_references":{"Chinese Clinical Trial Register":["ChiCTR-IOR-16008843"]}}